Questionable content of an industry-supported medical school lecture series: a case study
Open Access
- 11 June 2013
- journal article
- case report
- Published by BMJ in Journal of Medical Ethics
- Vol. 40 (6) , 414-418
Abstract
Background Medical schools are grappling with how best to manage industry involvement in medical education. Objective To describe a case study of industry-supported undergraduate medical education related to opioid analgesics. Method Institutional case study. Results As part of their regular curriculum, Canadian medical students attended pain pharmacotherapy lectures that contained questionable content about the use of opioids for pain management. The lectures were supported by pharmaceutical companies that market opioid analgesics in Canada and the guest lecturer was a member of speakers bureaus of the same companies. These conflicts of interests were not fully disclosed. A reference book that reinforced some of the information in the lectures and that was paid for by a sponsoring company was made available to students. This is the first report of an association between industry sponsorship and the dissemination of potentially dangerous information to medical students. Conclusions This case demonstrates the need for better strategies for preventing, identifying and dealing with problematic interactions between the pharmaceutical industry and undergraduate medical education. These might include the avoidance of unnecessary conflicts of interest, more disclosure of conflicts, an open process for dealing with recognised problems and internationally harmonised conflict of interest policies.Keywords
This publication has 30 references indexed in Scilit:
- Effect of Educational Interventions and Medical School Policies on Medical Studentsʼ Attitudes Toward Pharmaceutical Marketing Practices: A Multi-Institutional StudyAcademic Medicine, 2011
- Opioids for chronic noncancer pain: a new Canadian practice guidelineCanadian Medical Association Journal, 2010
- Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodoneCanadian Medical Association Journal, 2009
- Opioid Rotation: The Science and the Limitations of the Equianalgesic Dose TableJournal of Pain and Symptom Management, 2009
- The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health TragedyAmerican Journal of Public Health, 2009
- Research Gaps on Use of Opioids for Chronic Noncancer Pain: Findings From a Review of the Evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice GuidelineThe Journal of Pain, 2009
- Responses of Medical Schools to Institutional Conflicts of InterestJAMA, 2008
- The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United StatesPLOS Medicine, 2008
- Increasing deaths from opioid analgesics in the United StatesPharmacoepidemiology and Drug Safety, 2006
- AAMC FocusJournal of the Association of American Medical Colleges, 1997